A Phase 4 Study to Assess the Impact of Patient Support Program on Health Related Quality of Life and Adherence in Subjects With Relapsing-Remitting Multiple Sclerosis Administered Rebif® With the RebiSmart™ Device
Clinical trial NCT01791244 · COMPLETED
Trial details
- NCT number
- NCT01791244
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-28
- Primary completion
- 2016-02-29
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.